Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000609281 | SCV000728301 | likely benign | not specified | 2018-03-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000863768 | SCV001004480 | likely benign | Charcot-Marie-Tooth disease axonal type 2F | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000609281 | SCV001879774 | benign | not specified | 2020-11-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002275099 | SCV002563958 | benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | HSPB1: BS1, BS2 |
Ambry Genetics | RCV002331083 | SCV002629087 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |